These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10807806)

  • 1. Who gets chemotherapy for metastatic lung cancer?
    Earle CC; Venditti LN; Neumann PJ; Gelber RD; Weinstein MC; Potosky AL; Weeks JC
    Chest; 2000 May; 117(5):1239-46. PubMed ID: 10807806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
    Bittoni MA; Arunachalam A; Li H; Camacho R; He J; Zhong Y; Lubiniecki GM; Carbone DP
    Clin Lung Cancer; 2018 Sep; 19(5):e629-e645. PubMed ID: 29885945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.
    Arunachalam A; Li H; Bittoni MA; Camacho R; Cao X; Zhong Y; Lubiniecki GM; Carbone DP
    Clin Lung Cancer; 2018 Sep; 19(5):e783-e799. PubMed ID: 29983370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.
    Ramsey SD; Howlader N; Etzioni RD; Donato B
    J Clin Oncol; 2004 Dec; 22(24):4971-8. PubMed ID: 15611512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
    Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
    Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims data.
    Feliciano J; Gardner L; Hendrick F; Edelman MJ; Davidoff A
    Lung Cancer; 2015 Jan; 87(1):59-64. PubMed ID: 25443272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer.
    Wang J; Kuo YF; Freeman J; Markowitz AB; Goodwin JS
    Cancer; 2008 Jan; 112(2):382-90. PubMed ID: 18041068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of referral patterns on the use of chemotherapy for lung cancer.
    Earle CC; Neumann PJ; Gelber RD; Weinstein MC; Weeks JC
    J Clin Oncol; 2002 Apr; 20(7):1786-92. PubMed ID: 11919235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer.
    Ahmad U; Crabtree TD; Patel AP; Morgensztern D; Robinson CG; Krupnick AS; Kreisel D; Jones DR; Patterson GA; Meyers BF; Puri V
    Ann Thorac Surg; 2017 Jul; 104(1):303-307. PubMed ID: 28433225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy and age-related biases in non-small cell lung cancer.
    Rodriguez KA; Guitron J; Hanseman DJ; Williams V; Starnes SL
    Ann Thorac Surg; 2012 Dec; 94(6):1810-4. PubMed ID: 23103001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
    J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of care for older patients with stage IV non-small cell lung cancer in the immunotherapy era.
    Kehl KL; Hassett MJ; Schrag D
    Cancer Med; 2020 Mar; 9(6):2019-2029. PubMed ID: 31989786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse population.
    Rasco DW; Yan J; Xie Y; Dowell JE; Gerber DE
    J Thorac Oncol; 2010 Oct; 5(10):1529-35. PubMed ID: 20631635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy and safety of chemotherapy for patients with wet stage IIIB/IV non-small-cell lung cancer aged 80 years old or more.
    Tamiya A; Naito T; Ono A; Ayabe E; Tsuya A; Nakamura Y; Kaira K; Murakami H; Takahashi T; Endo M; Yamamoto N
    Lung Cancer; 2011 Feb; 71(2):173-7. PubMed ID: 20570388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease.
    Sigel K; Mhango G; Cohen J; Halm EA; Mandeli J; Strauss G; Wisnivesky J
    Ann Surg Oncol; 2013 Mar; 20(3):1013-9. PubMed ID: 23115004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?
    Sacher AG; Le LW; Lau A; Earle CC; Leighl NB
    Cancer; 2015 Aug; 121(15):2562-9. PubMed ID: 25891153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003.
    Dinan MA; Curtis LH; Carpenter WR; Biddle AK; Abernethy AP; Patz EF; Schulman KA; Weinberger M
    J Clin Oncol; 2012 Aug; 30(22):2725-30. PubMed ID: 22753917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer.
    Schroeder MC; Tien YY; Wright K; Halfdanarson TR; Abu-Hejleh T; Brooks JM
    Lung Cancer; 2016 May; 95():28-34. PubMed ID: 27040848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.